BIOMAT Database Logo BIOMAT Database Logo

Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection. 2006

Rong Xu, and Indresh K Srivastava, and Larene Kuller, and Irina Zarkikh, and Zane Kraft, and Zahra Fagrouch, and Norman L Letvin, and Jonathan L Heeney, and Susan W Barnett, and Leonidas Stamatatos
Seattle Biomedical Research Institute, Seattle, WA 98109, USA.

Immunization by the SF162gp140 or the DeltaV2gp140 HIV-1 envelope proteins results in the generation of strong homologous neutralizing antibodies (NAbs) that offer similar degree of protection from disease-development to macaques challenged with homologous virus. These two immunogens elicit weak cross-reactive NAbs and their effectiveness against heterologous challenge is currently unknown. To examine this issue, we immunized macaques with SIVGag p55 and either the SF162gp140 or the DeltaV2gp140 and challenged them intravenously with SHIV-89.6P. All animals became infected but previous immunization with SF162gp140 accelerated the development of anti-SHIV89.6P neutralizing antibody responses following infection. DeltaV2gp140 is derived from SF162gp140 following the deletion of 30 amino acids and one N-linked glycosylation site from the V2 loop. Our results suggest that even small differences in HIV Envelope immunogen structure can affect the neutralizing antibody responses generated following infection.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D015302 Simian Immunodeficiency Virus Species of the genus LENTIVIRUS, subgenus primate immunodeficiency viruses (IMMUNODEFICIENCY VIRUSES, PRIMATE), that induces acquired immunodeficiency syndrome in monkeys and apes (SAIDS). The genetic organization of SIV is virtually identical to HIV. SIV (Simian immunodeficiency virus),Immunodeficiency Viruses, Simian,Simian Immunodeficiency Viruses,Immunodeficiency Virus, Simian
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated

Related Publications

Rong Xu, and Indresh K Srivastava, and Larene Kuller, and Irina Zarkikh, and Zane Kraft, and Zahra Fagrouch, and Norman L Letvin, and Jonathan L Heeney, and Susan W Barnett, and Leonidas Stamatatos
Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection.
September 2006, Journal of virology,
Rong Xu, and Indresh K Srivastava, and Larene Kuller, and Irina Zarkikh, and Zane Kraft, and Zahra Fagrouch, and Norman L Letvin, and Jonathan L Heeney, and Susan W Barnett, and Leonidas Stamatatos
Prior infection with a nonpathogenic chimeric simian-human immunodeficiency virus does not efficiently protect macaques against challenge with simian immunodeficiency virus.
July 1995, Journal of virology,
Rong Xu, and Indresh K Srivastava, and Larene Kuller, and Irina Zarkikh, and Zane Kraft, and Zahra Fagrouch, and Norman L Letvin, and Jonathan L Heeney, and Susan W Barnett, and Leonidas Stamatatos
Immunization with recombinant macaque major histocompatibility complex class I and II and human immunodeficiency virus gp140 inhibits simian-human immunodeficiency virus infection in macaques.
July 2012, The Journal of general virology,
Rong Xu, and Indresh K Srivastava, and Larene Kuller, and Irina Zarkikh, and Zane Kraft, and Zahra Fagrouch, and Norman L Letvin, and Jonathan L Heeney, and Susan W Barnett, and Leonidas Stamatatos
Infection of a chimeric simian and human immunodeficiency virus with CCR5-specific HIV-1 envelope to Rhesus macaques.
February 2003, The Journal of veterinary medical science,
Rong Xu, and Indresh K Srivastava, and Larene Kuller, and Irina Zarkikh, and Zane Kraft, and Zahra Fagrouch, and Norman L Letvin, and Jonathan L Heeney, and Susan W Barnett, and Leonidas Stamatatos
Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection.
January 1993, Journal of virology,
Rong Xu, and Indresh K Srivastava, and Larene Kuller, and Irina Zarkikh, and Zane Kraft, and Zahra Fagrouch, and Norman L Letvin, and Jonathan L Heeney, and Susan W Barnett, and Leonidas Stamatatos
"Resistance" to PSC-RANTES revisited: two mutations in human immunodeficiency virus type 1 HIV-1 SF162 or simian-human immunodeficiency virus SHIV SF162-p3 do not confer resistance.
June 2010, Journal of virology,
Rong Xu, and Indresh K Srivastava, and Larene Kuller, and Irina Zarkikh, and Zane Kraft, and Zahra Fagrouch, and Norman L Letvin, and Jonathan L Heeney, and Susan W Barnett, and Leonidas Stamatatos
Simian immunodeficiency virus SIVmac239 infection and simian human immunodeficiency virus SHIV89.6P infection result in progression to AIDS in cynomolgus macaques of Asian origin.
December 2016, The Journal of general virology,
Rong Xu, and Indresh K Srivastava, and Larene Kuller, and Irina Zarkikh, and Zane Kraft, and Zahra Fagrouch, and Norman L Letvin, and Jonathan L Heeney, and Susan W Barnett, and Leonidas Stamatatos
Infection of rhesus macaques with a pool of simian immunodeficiency virus with the envelope genes from acute HIV-1 infections.
November 2016, AIDS research and therapy,
Rong Xu, and Indresh K Srivastava, and Larene Kuller, and Irina Zarkikh, and Zane Kraft, and Zahra Fagrouch, and Norman L Letvin, and Jonathan L Heeney, and Susan W Barnett, and Leonidas Stamatatos
Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge.
November 2003, Journal of virology,
Rong Xu, and Indresh K Srivastava, and Larene Kuller, and Irina Zarkikh, and Zane Kraft, and Zahra Fagrouch, and Norman L Letvin, and Jonathan L Heeney, and Susan W Barnett, and Leonidas Stamatatos
Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.
January 1998, AIDS (London, England),
Copied contents to your clipboard!